GRPR and neoplasm: The potent GRPR binding affinity (Ki) of Ga-TacsBOMB2 at a low nM scale contributes to the good uptake of [68Ga]Ga-TacsBOMB2 in human prostate cancer PC-3 tumor xenografts (10.2 ± 2.27%ID/g) at 1 h post-injection.